2022
DOI: 10.1080/10428194.2022.2087070
|View full text |Cite
|
Sign up to set email alerts
|

TP53/PLCG2-mutated diffuse large B-cell lymphoma richter transformation (DLBCL-RT) of CLL with unusual CD2 and PD-1 expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…(29) PLCG2 is located at 16q23 and is commonly mutated in chronic lymphocytic leukemia (CLL) and rare diffuse large B cell lymphomas. (30,31) While PLCG1 mutation was reported in T cell lymphomas, PLCG2 is rarely detected and is likely not contributory to the patient's phenotype. (32,33)…”
Section: Discussionmentioning
confidence: 99%
“…(29) PLCG2 is located at 16q23 and is commonly mutated in chronic lymphocytic leukemia (CLL) and rare diffuse large B cell lymphomas. (30,31) While PLCG1 mutation was reported in T cell lymphomas, PLCG2 is rarely detected and is likely not contributory to the patient's phenotype. (32,33)…”
Section: Discussionmentioning
confidence: 99%